Multiple Sclerosis Trial, Not Yet Recruiting NCT07310862 Sponsor: Clarity Health Technologies, Inc Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07310862
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 65 years (inclusive) on the day they sign the consent form.
  • People who have been diagnosed with MS (using the 2017 McDonald criteria) and who score above 33 on the Modified Fatigue Impact Scale, or above 4 out of 7 on the Fatigue Severity Scale.
  • People with sufficient hearing and vision to participate.
  • People taking any type of disease-modifying therapy, as long as the therapy has been stable for the past 3 months.
  • People who have not received corticosteroids in the month before joining the trial.
  • People who sign the informed consent form before any study assessments take place, in line with local requirements.
  • People who, in the investigator's judgment, are able to speak, read, and understand the language used by the trial staff and in the consent form.
  • People who are able to respond verbally to questions, follow instructions, and complete study tasks.
  • People who are able to follow the stimulation schedule and attend required visits.
  • Women who could become pregnant must have a negative urine pregnancy test before joining the study, and must agree to use a highly effective form of contraception throughout the study (such as an intrauterine device, implant, patch, pill, bilateral tubal occlusion, vasectomized partner, or sexual abstinence).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with any condition or ongoing treatment that could interfere with taking part in the trial or completing its assessments.
  • People who have had an MS relapse, or who have received intravenous steroids for any reason, in the 3 months before the screening visit.
  • People with serious systemic illnesses, or a personal or family history of cancer or hereditary cancer conditions.
  • People with clinically significant ongoing health conditions affecting the heart, digestive system, liver, lungs, nervous system, kidneys, or other major organs.
  • People with a history of seizures or epilepsy.
  • People who are pregnant or breastfeeding.
  • People with a history of drug or alcohol misuse.
  • People with an active bacterial, viral, or fungal infection, or those known to have uncontrolled AIDS, or those who are HIV-positive and not currently receiving anti-retroviral treatment, based on medical history or information available at screening.
  • People with dementia, or severe psychiatric, cognitive, or behavioural difficulties that may make it difficult to follow the study protocol.
  • People who, in the investigator's opinion, would be placed at risk by participating in the study due to any other relevant medical or surgical condition.
  • People who have participated in another experimental study within the 90 days before the screening visit.
  • People who have a pacemaker or other metal implants.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33781261622

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Clarity Health Technologies, Inc
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change in Modified Fatigue Impact Scale (MFIS) total score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov